Charles D. Chen

I am a postdoctoral research fellow at Centile Bio and Lund University, where I am supported by a DDLS Postdoctoral Fellowship to work on creating synthetic tau-PET images from MRI, which may be useful when tau-PET imaging is not accessible for detecting Alzheimer disease tauopathy. Previously I was a postdoctoral research fellow at the Martinos Center, where I was supported by a T32 fellowship. I did my PhD in Imaging Science at Washington University in St. Louis, where I was supported by the NSF GRFP and the Knight ADRC T32 Program.

Email | CV | Google Scholar | LinkedIn

Education and training

Post-doctoral research

Boston, Massachusetts | 2023-2026

After graduate school I worked on characterizing the extracerebral off-target signal (OTS) of 18F-MK-6240 tau PET. 18F-MK-6240 tau PET is a powerful tool for measuring Alzheimer disease (AD) tauopathy, but its extracerebral OTS can spill into the brain parenchyma and create the appearance of AD tauopathy. But when I developed a method to characterize this extracerebral OTS at a more granular level, namely by looking across different cortical depths and folding patterns instead of averaging 18F-MK-6240 uptake across large brain regions, I found that extracerebral OTS spill-in tends to create higher 18F-MK-6240 uptake values at the pial surfaces of gyri, while true AD tauopathy tends to create higher 18F-MK-6240 uptake values at the midthickness surfaces of gyri. Additionally, sulci tend not to be impacted by extracerebral OTS spill-in, but can be affected by AD tauopathy.

HAI 2026

San Juan, Puerto Rico | January 12, 2026

Oral presentation
The effects of 18F-MK-6240 PET extracerebellar off-target signal on the cerebellum and its substructures

Abstract

Chen et al. 2026

Alzheimer's and Dementia | January 8, 2026

Research article
Identifying early changes in imaging, plasma, and digital cognitive biomarkers that correspond to Alzheimer's disease pathology in the presence of autopsy-confirmed co-pathologies

Paper

AAIC 2025

Toronto, Canada | July 28, 2025

Poster presentation
Preliminary autopsy findings from the Harvard Aging Brain Study

Poster

McCullough et al. 2025

Alzheimer's and Dementia | July 14, 2025

Research article
Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial

Paper

Chen et al. 2025

Acta Neuropathologica | June 3, 2025

Research article
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease

Paper

HAI 2025

San Juan, Puerto Rico | January 16, 2025

Poster presentation | Blitz talk
Two distinct sources of 18F-MK-6240 off-target signal identified by individualized head modeling and PET kinetics

Abstract | Poster | Slide

AAIC 2024

Philadelphia, Pennsylvania | July 28, 2024

Poster presentation
Anti-Aβ treatment effects on dominantly inherited AD: comparing neuropathology findings with biomarker outcomes from the DIAN-TU-001 trial of gantenerumab or solanezumab

Poster

AANP 2024

Olympic Valley, California | June 7, 2024

Oral presentation (AANP Travel Award)
Autopsy findings versus biomarker outcomes in a clinical trial of anti-Aβ therapies in dominantly inherited Alzheimer disease

Slides

AD/PD 2024

Lisbon, Portugal | March 9, 2024

Oral presentation
Anti-amyloid-beta treatment effects on dominantly inherited Alzheimer disease neuropathology: Preliminary autopsy findings from the DIAN-TU-001 trial of gantenerumab or solanezumab

Slides

PET/MR in ADRD T32 Fellowship

Boston, Massachusetts | August 1, 2023

"The main goal of this T32 program is to provide a 2-year postdoctoral training experience, rich in multimodal neuroimaging, that focuses on three key research areas in Alzheimer’s disease and AD-related dementias (AD/ADRD): [1] the biology of aging and neurodegeneration; [2] data sciences, computational biology, statistics, mathematics, engineering, biophysics; and [3] drug discovery and drug development disciplines."

Website

Graduate research

St. Louis, Missouri | 2018-2023

In graduate school I worked on studying how well PET imaging could be used to diagnose and monitor Alzheimer disease (AD). One way to do this is to see how well antemortem PET imaging compares with postmortem neuropathology. To faciliate these sorts of studies, I co-founded the Pathology And Imaging Neuroinflammation and Tau (PAINT) committee to coordinate tissue transfers between the Knight ADRC Imaging and Neuropathology Cores, and joined the Dominantly Inherited Alzheimer Network (DIAN) to study autosomal dominant AD, which is thought to be a relatively "pure" form of AD as it is almost entirely driven by genetics as opposed to environmental factors. Together, these efforts resulted in the publication of several studies comparing antemortem PET imaging with postmortem neuropathology in autosomal dominant and sporadic AD. Interestingly, our estimate of the typical amount of amyloid-β plaque that accumulates in the brain during AD has, among other things, been used by other investigators to estimate whether removing amyloid-β plaques during anti-amyloid-β antibody treatment could lead to brain shrinkage.

I also took part in some research into anti-amyloid-β antibody therapies through the first clinical trial in dominantly inherited AD (DIAN-TU-001). Again, I compared antemortem PET imaging with postmortem neuropathology, but to deal with the demands of this larger study, I developed an automated method to quantify the levels of amyloid-β deposition, tauopathy, microgliosis, and astrocytosis from hundreds of brain tissue sections. Using this approach, I found that while the anti-amyloid-β therapies we studied do remove some amyloid-β deposits, they didn't seem to alter the levels of tauopathy, microgliosis, and astrocytosis in the brain. In the DIAN-TU-001, I also led or co-led projects investigating the consequences of a major side effect of anti-amyloid-β antibodies (amyloid-releated imaging abnormalities, or ARIA) as well as the feasibility of switching between different amyloid-β PET radioligands for monitoring amyloid-β removal in the event that one is unavailable. Beyond the DIAN-TU-001, I also led a project evaluating the reliability of the first FDA-approved tau-PET radioligand (18F-flortaucipir) for detecting AD tauopathy and found that the manufacturer's guidelines for the visual interpretation of these images did not cover cases such as hemorrhagic infacts and meningiomas, which can imitate the appearance of tau pathology.

Chen et al. 2023

Journal of Alzheimer's Disease | May 16, 2023

Research article
Comparing tau PET visual interpretation with tau PET quantification, CSF biomarkers, and longitudinal clinical assessment

Paper

Poletsky Award

St. Louis, Missouri | April 11, 2023

"The Richard and Mildred Poletsky Education Fund was initiated in 1995 by the family of Mr. Richard Poletsky, a native of St. Louis and alumnus of Washington University. Beginning in 1996, Mrs. Poletsky presented the award annually in memory of her husband until her death in 2016. Rhonda & David Banford continue to support the Poletsky Award in honor of Rhonda’s parents and almost always attend the recognition ceremony. The award is intended to enhance the career development of a promising student or fellow working towards a research, clinical and/or other service career focusing on aging and dementia."

News

Dissertation Defense

St. Louis, Missouri | April 10, 2023

Dissertation
To ascertain scientific reliability in PET imaging for Alzheimer disease

Dissertation

Chen et al. 2023

European Journal of Nuclear Medicine and Molecular Imaging | April 5, 2023

Research article
Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease

Paper

RSNA 2021

Chicago, Illinois | November 29, 2021

Oral presentation
Concordance of PET tau visual reads with PET tau quantification and CSF pTau

Slides

Chen et al. 2021

Acta Neuropathologica | July 28, 2021

Research article
Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease

Paper

Knight ADRC T32 Fellowship

St. Louis, Missouri | June 1, 2021

"The Washington University T32 training grant 'Multidisciplinary Training in Alzheimer and Related Dementias' is designed to prepare the next generation of researchers in Alzheimer disease and related dementias. The program emphasizes the collaborative, multi- disciplinary research that will be needed to find treatments for Alzheimer disease and other dementias."

Application | Website

Chen et al. 2020

Annals of Clinical and Translational Neurology | November 5, 2020

Research article
Ante- and postmortem tau in autosomal dominant and late-onset Alzheimer’s disease

Paper

AAIC 2020

Virtual | July 28, 2020

Oral presentation
Tauopathy in autosomal dominant and late-onset Alzheimer disease

Slides

HAI 2020

Miami, Florida | January 16, 2020

Poster presentation (Young Investigator Award Finalist)
Quantifying tau PET imaging reliably in the presence of off-target binding

Poster

Zhang et al. 2018

Current Biology | December 20, 2018

Research article
Novelty, Salience, and Surprise Timing Are Signaled by Neurons in the Basal Forebrain

Paper

Cottaar et al. 2018

Neuroimage | August 1, 2018

Research article
A gyral coordinate system predictive of fibre orientations

Paper

NSF Graduate Research Fellowship Program

St. Louis, Missouri | April 3, 2018

"The purpose of the NSF Graduate Research Fellowship Program (GRFP) is to help ensure the quality, vitality, and diversity of the scientific and engineering workforce of the United States. A goal of the program is to broaden participation of the full spectrum of diverse talents in STEM. The five-year fellowship provides three years of financial support inclusive of an annual stipend of $37,000."

Application | Website

Post-baccalaurate research

St. Louis, Missouri | 2015-2018

After college I worked with Dr. Ilya Monosov to study the brain as it learned risks and rewards in an uncertain environment. My thought back then was that studying how biological neurons encoded risks and rewards could inform the design of artificial neural networks. At the time, there was a breakthrough in using neural networks to learn how to play video games without human supervision by using "only the pixels and the game score as inputs". However, when watching videos of the neural network's performance, I noticed it often failed to learn how to play games where the game score increased very rarely. I thought one way to remedy this was to design a cost function that could "motivate" the network to learn how to play in the absence of frequent rewards.

I kept this in mind as I ran experiments to measure a monkey's neuronal activity in the basal forebrain while it watched visual cues that indicated the probability that it would receive a fruit juice reward in the next few seconds. I ended up characterizing two neuronal signals: one was a pre-reward ramping signal that was associated with anticipating a probablistic reward in the future, and the other was a post-reward spiking signal that was associated with receiving a reward that had a low probability of occuring. I felt these signals could be useful in the context mentioned earlier: pre-reward ramping ties together a visual cue and possible future reward, even though they don't occur simultaneously, and post-reward spiking draws the most attention to the rarest rewards, and could be a powerful learning signal in the absence of frequent rewards.

AAIC 2018

Chicago, Illinois | July 23, 2018

Poster presentation
Evaluating neuroinflammation imaging as a biomarker of tissue cellularity in the post-mortem human brain

Poster

Ledbetter et al. 2016

Journal of Neuroscience | July 27, 2016

Research article
Multiple Mechanisms for Processing Reward Uncertainty in the Primate Basal Forebrain

Paper

Undergraduate research

St. Louis, Missouri | 2011-2015

In college I worked with Drs. David Van Essen, Matt Glasser, and Krikor Dikranian on a problem they called the "gyral bias". Drs. Van Essen and Glasser were using diffusion MRI to estimate the trajectories of axonal fibers that connect different parts of the brain together. Diffusion MRI suggested that more axonal fibers terminated in gyral crowns than in sulcal banks or fundi. However, Dr. Dikranian found that in postmortem brain tissue that has been stained to visualize axonal fibers, the fibers appeared to terminate evenly along the cortical surface with no preference for gyral crowns. Clearly the diffusion MRI fiber estimates needed to be improved to reflect this, but it was not clear how to quantify the observations from postmortem brain tissue so they can be used to correct these estimates.

First I worked on a way to quantify axonal fiber directions with respect to the cortical surfaces from the postmortem brain tissue. In the beginning, I was given the brain tissue, a microscope, a pencil, and a stack of paper, and I was asked to draw what I saw. This took a lot of time, and I felt that even if I drew the axonal fibers perfectly, they would never be quantitative. I decided to digitize the tissue sections. Then I manually annotated the axonal fibers using Adobe Illustrator, a vector graphics software, which gave a quantitative measure of fiber directions. This still took a lot of time, though, so I taught myself how to code in MATLAB, and wrote a script that estimated axonal fiber directions (using structure tensors) with respect to the cortical surface (delineated using B-splines).

With the ability now to quantify where and by how much axonal fiber directions differed between digital microscopy and diffusion MRI, our findings spun off several new approaches for estimating the trajectories that axonal fibers take when terminating in cerebral cortex. These findings also received pushback from other investigators who believed there was no "gyral bias" and that fiber directions estimated by diffusion MRI always reflected the true fiber architecture of the brain. At the time, using diffusion MRI to estimate axonal fiber trajectories was still a relatively recent development, and I'm sure people were very excited by the possibilities and were happy to overlook the limitations. But now, it's hard to argue that there haven't been substantial improvements to diffusion MRI since then, and that maybe the earlier attempts did indeed have issues like the "gyral bias" that were corrected later.

Visiting Scholar

Oxford, UK | September 8, 2015

"The FMRIB Building and FMRIB Annexe are on the John Radcliffe Hospital Site in Headington, Oxford. As well as hosting around 100 researchers, the FMRIB Building is the location of one of our 3 Tesla MRI scanners and our 7 Tesla Human MRI. The FMRIB Annexe, just across the car park from the FMRIB building, hosts another 60 researchers and most of our meeting rooms."

Website

Senior Honors Thesis

St. Louis, Missouri | April 17, 2015

Thesis
Comparison of Diffusion MRI with Axonal Trajectories Near Cortex to Estimate Folding-Related Biases of Tractography-based Connectivity in the Macaque Brain

Thesis

Van Essen et al. 2014

Diffusion MRI: From Quantitative Measurement to In vivo Neuroanatomy | November 4, 2013

Book chapter
Mapping Connections in Humans and Non-Human Primates: Aspirations and Challenges for Diffusion Imaging

Book chapter

HHMI Summer Undergraduate Research Fellowship

St. Louis, Missouri | April 5, 2013

"The Summer Undergraduate Research Fellows (SURF), funded by the Howard Hughes Medical Institute and various other agencies, is an opportunity for freshmen, sophomores and juniors to apply for a 10 week research project with faculty mentors, earning a summer stipend."

Slides | Poster

ISMRM 2013

Salt Lake City, Utah | April 26, 2013

Oral presentation (ISMRM Merit Award summa cum laude)
Comparison of Diffusion MRI Predictions and Histology in the Macaque Brain

Abstract | Slides

National Merit Scholarship

Kansas City, Missouri | May 4, 2011

"The National Merit Scholarship Program is an annual academic competition among high school students for recognition and college scholarships that began in 1955. The program is conducted by National Merit Scholarship Corporation (NMSC®), a not-for-profit organization that operates without government assistance. United States high school students enter the National Merit Scholarship Program by taking the Preliminary SAT/National Merit Scholarship Qualifying Test (PSAT/NMSQT®), which serves as an initial screen of over 1.3 million entrants each year, and by meeting published program entry and participation requirements."

Website